Intestinal anti-inflammatory activity of calcium pyruvate in the TNBS model of rat colitis: Comparison with ethyl pyruvate

Biochemical Pharmacology
F AlgieriJulio Gálvez

Abstract

Pyruvate is a key intermediate of the carbohydrate metabolism with endogenous scavenger properties. However, it cannot be used in clinics due to its instability. Ethyl pyruvate (EP) has shown better stability as well as an antioxidant and anti-inflammatory activity. Calcium pyruvate monohydrate (CPM) is another stable pyruvate derivative that could also provide the benefits from calcium, fundamental for bone health. Considering everything, we propose CPM as a therapeutic strategy to treat diseases with an immune component in which there is also a significant dysregulation of the skeletal homeostasis. This could be applicable to inflammatory bowel disease, which is characterized by over-production of pro-inflammatory mediators, including cytokines and reactive oxygen and nitrogen metabolites that induces intestinal mucosal damage and chronic inflammation, and extra-intestinal symptoms like osteopenia and osteoporosis. The effects of CPM and EP (20, 40 and 100mg/kg) were evaluated on the trinitrobenzenesulfonic acid (TNBS) model of colitis in rats, after a 7-day oral treatment, with main focus on colonic histology and inflammatory mediators. Both pyruvates showed intestinal anti-inflammatory effects in the TNBS-induced colitis. T...Continue Reading

References

Oct 1, 1995·Gastroenterology·C O ElsonR H Riddell
Apr 1, 1997·Journal of the American Academy of Nurse Practitioners·S J WhitingK Kim
Jun 18, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·Runkuan YangMitchell P Fink
Sep 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Luis UlloaKevin J Tracey
Sep 5, 2003·Intensive Care Medicine·Takashi UchiyamaMitchell P Fink
Nov 10, 2004·British Journal of Pharmacology·Desiree CamuescoJulio Gálvez
Mar 1, 2005·Inflammatory Bowel Diseases·Desiree CamuescoJulio Galvez
Jun 9, 2006·Current Opinion in Gastroenterology·Sarah A De La Rue, Stephen J Bickston
Aug 19, 2006·Inflammatory Bowel Diseases·Gary R LichtensteinMichael Pazianas
Mar 3, 2007·The Journal of Clinical Investigation·Warren StroberPeter Mannon
Jun 5, 2007·Current Opinion in Gastroenterology·Joachim Mankertz, Jörg-Dieter Schulzke
Aug 7, 2007·Nature Immunology·Nicholas J WilsonRene de Waal Malefyt
Apr 30, 2008·Current Opinion in Anaesthesiology·Mitchell P Fink
Mar 3, 2009·Inflammatory Bowel Diseases·Clara Abraham, Judy Cho
May 21, 2009·Journal of Leukocyte Biology·Shaival H DavéScott E Plevy
Dec 10, 2009·World Journal of Gastroenterology : WJG·Zhan-Ju LiuKe Fei
Mar 23, 2010·Pulmonary Pharmacology & Therapeutics·Ayako MizutaniHideyuki Yamamoto
Jul 8, 2010·The Journal of Gene Medicine·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Jul 24, 2010·British Journal of Pharmacology·J C McGrathC L Wainwright
Jul 24, 2010·British Journal of Pharmacology·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Aug 13, 2010·Current Gastroenterology Reports·Young S Kim, Samuel B Ho
Dec 3, 2010·Journal of Crohn's & Colitis·A DignassUNKNOWN European Crohn's and Colitis Organisation (ECCO)
Jul 21, 2011·Nature Immunology·Andrea OeckinghausSankar Ghosh
Jun 19, 2013·Autoimmunity Reviews·Giovanni MonteleoneFrancesco Pallone
Aug 8, 2014·ISRN Inflammation·Julio Gálvez

❮ Previous
Next ❯

Citations

Dec 17, 2016·Journal of Inflammation·Runkuan YangTor Inge Tonnessen
Jul 25, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Chenxi LuQiang Wang
Sep 19, 2021·Cell Death & Disease·Na TianXuemei Tong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here